Kentaro Kinjo

1.8k total citations
38 papers, 1.5k citations indexed

About

Kentaro Kinjo is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kentaro Kinjo has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 16 papers in Molecular Biology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kentaro Kinjo's work include Acute Myeloid Leukemia Research (13 papers), Retinoids in leukemia and cellular processes (10 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Kentaro Kinjo is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Retinoids in leukemia and cellular processes (10 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Kentaro Kinjo collaborates with scholars based in Japan, United States and India. Kentaro Kinjo's co-authors include Hideyuki Okano, Yumi Matsuzaki, Richard C. Mulligan, Yasuo Ikeda, Deepa Shankar, Kathleen M. Sakamoto, Kiyoshi Ando, Yukari Muguruma, Masahiro Kizaki and Hiroshi Kawada and has published in prestigious journals such as Blood, Immunity and Cancer Cell.

In The Last Decade

Kentaro Kinjo

37 papers receiving 1.4k citations

Peers

Kentaro Kinjo
P. Koistinen Finland
RG Smith United States
Deborah L. Ornstein United States
Diane E. Cole United States
Erwin A. Kruger United States
F. Ries Luxembourg
Juha Rutanen Finland
Kentaro Kinjo
Citations per year, relative to Kentaro Kinjo Kentaro Kinjo (= 1×) peers Kazuo Matsui

Countries citing papers authored by Kentaro Kinjo

Since Specialization
Citations

This map shows the geographic impact of Kentaro Kinjo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kentaro Kinjo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kentaro Kinjo more than expected).

Fields of papers citing papers by Kentaro Kinjo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kentaro Kinjo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kentaro Kinjo. The network helps show where Kentaro Kinjo may publish in the future.

Co-authorship network of co-authors of Kentaro Kinjo

This figure shows the co-authorship network connecting the top 25 collaborators of Kentaro Kinjo. A scholar is included among the top collaborators of Kentaro Kinjo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kentaro Kinjo. Kentaro Kinjo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kinjo, Kentaro, Tomoko Sairenji, Hidenobu Koga, et al.. (2017). Cost of physician-led home visit care (Zaitaku care) compared with hospital care at the end of life in Japan. BMC Health Services Research. 17(1). 40–40. 27 indexed citations
3.
Shankar, Deepa, Jerry C. Cheng, Kentaro Kinjo, et al.. (2005). The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell. 7(4). 351–362. 199 indexed citations
4.
Kinjo, Kentaro, Salemiz Sandoval, Kathleen M. Sakamoto, & Deepa Shankar. (2005). The Role of CREB as a Proto-oncogene in Hematopoiesis. Cell Cycle. 4(9). 1134–1135. 48 indexed citations
5.
Nakazato, Tomonori, Keisuke Ito, Yoshitaka Miyakawa, et al.. (2005). Catechin, a green tea component, rapidly induces apoptosis of myeloid leukemic cells via modulation of reactive oxygen species production in vitro and inhibits tumor growth in vivo.. PubMed. 90(3). 317–25. 79 indexed citations
6.
Matsuzaki, Yumi, Kentaro Kinjo, Richard C. Mulligan, & Hideyuki Okano. (2004). Unexpectedly Efficient Homing Capacity of Purified Murine Hematopoietic Stem Cells. Immunity. 20(1). 87–93. 224 indexed citations
7.
Kinjo, Kentaro, Yoshitaka Miyakawa, Hideo Uchida, et al.. (2004). All-trans retinoic acid directly up-regulates thrombopoietin transcription in human bone marrow stromal cells. Experimental Hematology. 32(1). 45–51. 8 indexed citations
8.
9.
Ito, Keisuke, Kentaro Kinjo, Tomonori Nakazato, Y. Ikeda, & Masahiro Kizaki. (2002). Expression and sequence analyses of p33ING1 gene in myeloid leukemia. American Journal of Hematology. 69(2). 141–143. 19 indexed citations
10.
Awaya, Norihiro, Hideo Uchida, Yoshitaka Miyakawa, et al.. (2002). Novel variant isoform of G‐CSF receptor involved in induction of proliferation of FDCP‐2 cells: Relevance to the pathogenesis of myelodysplastic syndrome. Journal of Cellular Physiology. 191(3). 327–335. 14 indexed citations
11.
Takayama, Nobuyuki, Masahiro Kizaki, Takayuki Hida, Kentaro Kinjo, & Yasuo Ikeda. (2001). Novel mutation in the PML/RARα chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoic acid in acute promyelocytic leukemia. Experimental Hematology. 29(7). 864–872. 32 indexed citations
12.
Kinjo, Kentaro, Masahiro Kizaki, Akihiro Muto, et al.. (2000). Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice. Leukemia. 14(3). 431–438. 50 indexed citations
13.
Kinjo, Kentaro, Masahiro Kizaki, Nobuyuki Takayama, et al.. (1999). Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukaemia during all‐trans retinoic acid treatment. British Journal of Haematology. 105(2). 382–387. 6 indexed citations
15.
Kosugi, Takahiro, et al.. (1986). Purification and Some Chemical Properties of Thrombin-Like Enzyme from Trimeresurus Flavoviridis Venom. Thrombosis and Haemostasis. 55(1). 24–30. 27 indexed citations
16.
Oda, K, Y Tamao, Ryoji Kikumoto, et al.. (1980). Comparison of plasma levels and excretory routes between No. 189 and No. 407, potent thrombin inhibitors.. PubMed. 26(1). 11–31. 2 indexed citations
17.
Hijikata, Akiko, Shosuke Okamoto, Etsuko Mori, et al.. (1976). In vitro and in vivo studies of a new series of synthetic thrombin-inhibitors (OM-inhibitors). Thrombosis Research. 8(2 suppl). 83–89. 15 indexed citations
18.
Kinjo, Kentaro, et al.. (1963). STUDIES ON THE FIBRINOLYSIS IN TUMOR BEARING MICE. I. FIBRINOLYTIC SYSTEM, ASCITES RETENTION AND INTRAPERITONEAL HEMORRHAGE IN TUMOR BEARING MICE: SUPPRESSING EFFECT OF EPSILON AMINOCAPROIC ACID.. PubMed. 18. 151–60. 2 indexed citations
19.
Kinjo, Kentaro, H Mihara, & Y Funahara. (1963). STUDIES ON THE FIBRINOLYSIS IN TUMOR BEARING MICE. II. APPEARANCE OF FIBRINOLYTIC ENZYME IN ASCITES AFTER TUMOR CELLS INOCULATION.. PubMed. 18. 161–7. 1 indexed citations
20.
Amano, Tetsuki, et al.. (1955). Studies on the Immune Bacteriolysis. VI. Cause of the Death of Bacteria by Immune Bacteriolysis.. 6(1). 57–66. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026